Helicobacter pylori eradication therapy for the remnant stomach after gastrectomy

Gastric Cancer

Volumn 6, Issue 2, 2003, Pages 100-107

  Matsukura, Norio ^a   Tajiri, Takashi ^a   Kato, Shunji ^a   Togashi, Akiyoshi ^a   Masuda, Gotaro ^a   Fujita, Itsuo ^a   Tokunaga, Akira ^a   Yamada, Nobutaka ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Eradication; Helicobacter pylori; Remnant stomach; Sydney system; Triple therapy

Indexed keywords

12 SULFODEHYDROABIETIC ACID; AMOXICILLIN; CLARITHROMYCIN; LANSOPRAZOLE; METRONIDAZOLE; PROTON PUMP INHIBITOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIARRHEA; DISEASE ACTIVITY; ERADICATION THERAPY; FEMALE; GASTRECTOMY; GASTROESOPHAGEAL REFLUX; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATION; INTESTINE METAPLASIA; MALE; MULTIPLE CANCER; NAUSEA; NONHUMAN; POSTOPERATIVE CARE; PRIORITY JOURNAL; RASH; RISK FACTOR; SCORING SYSTEM; STOMACH CANCER; STOMACH GLAND; SYDNEY SYSTEM; TASTE DISORDER;

EID: 0037932772     PISSN: 14363291     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10120-003-0234-7     Document Type: Article

References (34)

1. Toftgaard C. Gastric cancer after peptic ulcer surgery: a historic prospective cohort investigation. Ann Surg 1989;210:159-64.
2. Fiore AC, Malangoni MA, Broadie TA, Madura JA, Jesseph JE. Surgical management of alkaline reflux gastritis. Arch Surg 1982;117:689-94.
3. Matsukura N, Onda M. Gastric remnant-stump cancer and Helicobacter pylori (in Japanese). Gastroenterol Surg 2000;23:1133-8.
4. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Schistosomes, liver flukes and Helicobacter pylori. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans 61. Lyon: IARC; 1994. p. 177-241.
5. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001;345:784-9.
6. Sugiyama A, Maruta F, Ikeno T, Ishida K, Kawasaki S, Katsuyama T, et al. Helicobacter pylori infection enhances N-methyl-N-nitrosourea-induced stomach carcinogenesis in the Mongolian gerbils. Cancer Res 1998;58:2067-9.
7. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process. First American Cancer Society Award Lecture On Cancer Epidemiology and Prevention. Cancer Res 1992;52:6735-40.
8. The European Helicobacter pylori study group. Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. Gut 1997;41:8-13.
9. Uemura N, Mukai T, Okamoto S, Yamaguchi S, Mashiba H, Taniyama K, et al. Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer. Cancer Epidemiol Biomarkers Prev 1997;6:639-42.
10. Saito K, Arai K, Mori M, Kobayashi R, Ohki I. Effect of Helicobacter pylori eradication on malignant transformation of gastric adenoma. Gastrointest Endosc 2000;52:27-32.
11. Nagahata Y, Kawakita N, Azumi Y, Numata N, Yano M, Saitoh Y. Etiological involvement of Helicobacter pylori in "reflux" gastritis after gastrectomy. Am J Gastroenterol 1996;91:2130-4.
12. Rino Y, Imada T, Shiozawa M, Takahashi M, Fukuzawa K, Hasuo K, et al. Helicobacter pylori of the remnant stomach and its eradication. Hepatogastroenterology 1999;46:2069-73.
13. Yamada N, Matsukura N, Matsuhisa T. Triple site biopsy under endoscopy (in Japanese with English abstract). Nippon Rinsho (Jpn J Clin Med) 2001;59:252-7.
14. Dixon MF, Genta RM, Yardely JH, Correa P. Classification and grading of gastritis. The updated Sydney system. Am J Surg Pathol 1996;20:1161-81.
15. Miki K, Ichinose M, Kawamura N, Matsushima M, Ahmad HB, Kimura M, et al. The significance of low serum pepsinogen levels to detect stomach cancer associated with extensive chronic gastritis in Japanese subjects. Jpn J Cancer Res 1989;80:111-4.
16. Shibata K, Ito Y, Hongo A, Yasoshima A, Endo T, Ohashi M. Bactericidal activity of a new antiulcer agent, ecabet sodium, against Helicobacter pylori under acidic conditions. Antimicrob Agents Chemother 1995;39:1295-9.
17. Watanabe T, Tada M, Nagai H, Sasaki S, Nakao M. Helicobacter pylori infection induces gastric cancer in Mongolian gerbils. Gastroenterology 1998;115:642-8.
18. Honda S, Fujioka T, Tokieda M, Satoh R, Nishizono A, Nasu M. Development of Helicobacter pylori-induced gastric carcinoma in Mongolian gerbils. Cancer Res 1998;58:4255-9.
19. Hirayama F, Takagi S, Iwao E, Yokoyama Y, Haga K, Hanada S. Development of poorly differentiated adenocarcinoma and carcinoid due to long-term Helicobacter pylori colonization in Mongolian gerbils. J Gastroenterol 1999;34:450-4.
20. Onoda N, Maeda K, Sawada T, Wakasa K, Arakawa T, Chung KH. Prevalence of Helicobacter pylori infection in gastric remnant after distal gastrectomy for primary gastric cancer. Gastric Cancer 2001;4:87-92.
21. Kikuchi S. Epidemiology of Helicobacter pylori and gastric cancer. Gastric Cancer 2002;5:6-15.
22. Blaser MJ, Chyou PH, Nomura A. Age at establishment of Helicobacter pylori infection and gastric carcinoma, gastric ulcer and duodenal ulcer risk. Cancer Res 1995;55:562-5.
23. Shimizu N, Ikehara Y, Inada K, Nakanishi H, Tsukamoto T, Nozaki K, et al. Eradication diminishes enhancing effects of Helicobacter pylori infection on glandular stomach carcinogenesis in Mongolian gerbils. Cancer Res 2000;60:1512-4.
24. Miwa H, Nagahata A, Sato K, Ohkura R, Murai T, Shimizu H, et al. Efficacy of 1 week omeprazole or lansoprazole-amoxicillin-clarithromycin therapy for Helicobacter pylori infection in the Japanese population. J Gastroenterol Hepatol 1999;14:317-21.
25. Nagata K, Satoh H, Iwahi T, Shimoyama T, Tamura T. Potent inhibitory action of the gastric proton pump inhibitor lansoprazole against urease activity of Helicobacter pylori: unique action selective for H. pylori cells. Antimicrob Agents Chemother 1993;37:769-74.
26. Kagaya H, Kato M, Komatsu Y, et al. High-dose ecabet sodium improves the eradication rate of Helicobacter pylori in dual therapy with lansoprazole and amoxicillin. Aliment Pharmacol Ther 2000;14:1523-7.
27. Takimoto T, Satoh K, Taniguchi Y, Saifuku K, Kihira K, Seki M, et al. The efficacy and safety of 1-week triple therapy with lansoprazole, clarithromycin, and metronidazole for the treatment of Helicobacter pylori infection in Japanese patients. Helicobacter 1997;2:86-91.
28. Kato M, Yamaoka Y, Kim JJ, Reddy R, Asaka M, Kashima K, et al. Regional differences in metronidazole resistance and increasing clarithromycin resistance among Helicobacter pylori isolates from Japan. Antimicrob Agents Chemother 2000;44:2214-6.
29. Murakami K, Sato R, Okimoto T, Nasu M, Fujioka T, Kodama M, et al. Efficacy of triple therapy comprising rabeprazole, amoxicillin and metronidazole for second-line Helicobacter pylori eradication in Japan, and the influence of metronidazole resistance. Aliment Pharmacol Ther 2003;17:119-23.
30. Labenz J, Blum AL, Bayerdörffer E, Meining A, Stolte M, Borsch G. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology 1997;112:1442-7.
31. Tomtitchong P, Onda M, Matsukura N, Tokunaga A, Kato S, Matsuhisa T, et al. Helicobacter pylori infection in the remnant stomach after gastrectomy: with special reference to the difference between Billroth I and II anastomosis. J Clin Gastroenterol 1998;27:S154-8.
32. Han SW, Evans DG, el-Zaatari FA, Go MF, Graham DY. The interaction of pH, bile and Helicobacter pylori may explain duodenal ulcer. Am J Gastroenterol 1996;91:1135-7.
33. 13C] urea breath test. J Clin Gastroenterol 1995;21:S146-50.
34. Asaka M, Kimura T, Kudo M, Takeda H, Mitani S, Miyazaki T, et al. Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population. Gastroenterology 1992;102:760-6.